The spike protein of SARS-CoV-2 binds to the ACE2 receptor
via
its
receptor-binding domain (RBD), with the RBD–ACE2 complex presenting an essential
molecular target for vaccine development to stall the virus infection proliferation. The
computational analyses at molecular, amino acid (AA), and atomic levels have been
performed systematically to identify the key interacting AAs in the formation of the
RBD–ACE2 complex for SARS-CoV and SARS-CoV-2 with its Alpha and Beta variants.
Our study uses the molecular dynamics (MD) simulations with the molecular mechanics
generalized Born surface area (MM-GBSA) method to predict the binding free energy (BFE)
and to determine the actual interacting AAs, as well as two
ab initio
quantum chemical protocols based on the density functional theory (DFT) implementation.
Based on MD results, Q
493
, Y
505
, Q
498
, N
501
,
T
500
, N
487
, Y
449
, F
486
, K
417
,
Y
489
, F
456
, Y
495
, and L
455
have been
identified as hotspots in SARS-CoV-2 RBD, while those in ACE2 are K
353
,
K
31
, D
30
, D
355
, H
34
, D
38
,
Q
24
, T
27
, Y
83
, Y
41
, and E
35
.
RBD with Alpha and Beta variants has slightly different interacting AAs due to N501Y
mutation. Both the electrostatic and hydrophobic interactions are the main driving force
to form the AA–AA binding pairs. We confirm that Q
493
,
Q
498
, N
501
, F
486
, K
417
, and F
456
in RBD are the key residues responsible for the tight binding of SARS-CoV-2 with ACE2
compared to SARS-CoV. RBD with the Alpha variant binds with ACE2 stronger than the
wild-type RBD or Beta. In the Beta variant, K417N reduces the binding, E484K slightly
enhances it, and N501Y significantly increases it as in Alpha. The DFT results reveal
that N
487
, Q
493
, Y
449
, T
500
,
G
496
, G
446
, and G
502
in RBD of SARS2 form pairs
via
specific hydrogen bonding with Q
24
, H
34
,
E
35
, D
38
, Y
41
, Q
42
, and K
353
in
ACE2.